PKO Investment Management Joint-Stock’s Charles River Laboratories CRL Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,700	Closed	-$266K	–	220
2025 Q3	$266K	Sell	1,700 -3,800	-69%	-$604K	0.02%	193
2025 Q2	$835K	Hold	5,500	–	–	0.09%	137
2025 Q1	$828K	Buy	+5,500	New	+$922K	0.09%	137
2024 Q4	–	Sell	-5,000	Closed	-$985K	–	157
2024 Q3	$985K	Buy	+5,000	New	+$1.04M	0.12%	108

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PKO Investment Management Joint-Stock's CRL Position: Q4 2025 in Review

PKO Investment Management Joint-Stock sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,700 shares — an estimated $266K sold.

PKO Investment Management Joint-Stock first reported a position in CRL in Q3 2024 and held it in 4 quarters. The position peaked at $985K in Q3 2024. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

PKO Investment Management Joint-Stock reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
PKO Investment Management Joint-Stock sold 1,700 Charles River Laboratories shares in Q4 2025, an estimated $266K.
PKO Investment Management Joint-Stock first reported a position in Charles River Laboratories in Q3 2024 and held it in 4 quarters.
PKO Investment Management Joint-Stock's Charles River Laboratories position peaked at $985K in Q3 2024.
581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on PKO Investment Management Joint-Stock's 13F filing for Q4 2025, filed 2 Feb 2026.